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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S1542005 and April 2009 and were diagnosed by the rheumatologist with
primary hand, knee or hip OA.
All subjects were followed until 2 November 2011.Mortality was compared
between included patients with OA and the general population in the
Netherlands, matched for both age and gender. For GARP, the expected
numbers of deaths came from age and gender speciﬁc mortality data
provided in the mortality statistics from 2006 in 5-year age bands and for
‘Zorgpad artrose’ the data came from 2009. Standardized Mortality Ratios
(SMR) with 95% conﬁdence intervals (95% CI) were calculated using STATA
(version 10.1).
Results: The GARP study consisted of 384 participants (82% women) and
the mean age at inclusion was 60.1 (range 42-79). The duration of follow-
up was 9.0 (SD 1.2). No excess mortality was observed in OA patients when
compared to the general population. 26 patients died, while the expected
number of deaths was 48 (SMR 0.54, 95% CI 0.37 - 0.79). The SMR was 0.47
(0.29 - 0.76) in women and 0.73 (0.39 - 1.35) in men. Healthy cohort effect
was also tested and not likely present.
In our replication cohort we found similar results (11 patients died, SMR
0.45, 95% CI 0.25 - 0.82). The SMR was also lower in women (0.40, 0.20 -
0.81) than in men (0.66, 0.21 - 2.06)
Conclusions: In patients consulting health care, OA does not lead to
a higher mortality rate in women and a similar trend can be observed
in men. These results do not support the hypothesis that metabolic
syndrome is an important cause of OA and would inﬂuence the
mortality of patients consulting primary or secondary health care for
their complaints. Whether this is due to selection of patients or
reﬂects a true absence of metabolic syndrome in OA has to be further
investigated.305
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Purpose: Statin medications are widely used and have been shown to
reduce inﬂammation in cardiovascular disease; animal data suggests
a protective role for statins in inﬂammation associated with cartilage and
bone. Based on these ﬁndings, we wanted to evaluate the association of
statin use with the risk of incident knee radiographic osteoarthritis
(ROA).
Methods: Subjects were enrolled in MOST, an NIH-funded cohort study of
3026 men and women ages 50-79 years with, or at high risk of knee OA.
Subjects had baseline and 30 month follow-up PA and lateral knee x-rays.
Tibiofemoral (TF) ROA was deﬁned as the presence of Kellgren/Lawrence
(K/L) grade  2. Whole knee (WK) ROA was deﬁned as the presence of
either TFROA or patellofemoral (PF) OA, deﬁned as either (1) PF osteophyte
grade  2, or 2) as a PF osteophyte grade  1 plus one or more of PF joint
space narrowing, sclerosis or cysts . Incident cases were knees without
TFROA (or WKROA) at baseline that developed it at 30 months. Statin useAssociation of Statin Use and Incident TFROA
OVERALL WOMEN
No use Continuous use No use
Subjects 1243 432 764
Knees 1962 655 1208
Events 153 (7.3%) 60 (8.4%) 100 (7.7
Unadjusted model ref 1.18 (0.85-1.63) 0.32 ref
Adjusted Model 1.13 (0.80-1.59) 0.49was determined by a review of current (past 30 days) prescription medi-
cations, brought to the clinic by participants, at the baseline and 30 month
visits. We used logistic regression in a knee based analysis, with GEE to
account for within-person correlation, to determine the association of
statin use at both the baseline and 30 month visit (“continuous use”)
compared to no statin use at either the baseline or 30 month visit (“no
use”) with outcomes of incident TFROA and incident WKROA. Analyses
were adjusted for age, race, clinic site, BMI and self-reported cardiovas-
cular disease.
Results: 2,830 knees from 1,675 subjects were eligible for incident TFROA
in subjects who had either “no use” (1,243 subjects) or “continuous use”
(432 subjects) of statins over the 30 month period. There were no signif-
icant differences in baseline characteristics of the two statin use groups
except for BMI [“no use”¼ 29.3  5.3; “continuous use”¼30.4  5.1; p-
value¼ 0.0006]. In men and women combined, there was no signiﬁcant
association between statin use and incident TFROA in the unadjusted
model (OR¼1.18 (0.85-1.63)), or after adjusting for covariates (OR¼ 1.13
(0.80-1.59)). Stratifying by gender suggested a different direction of asso-
ciation of statin use and TFROA in women compared to men [women:
adjusted OR¼ 1.37 (0.88-2.15); p-value¼ 0.17; men: adjusted OR¼ 0.84
(0.51-1.41); p-value¼ 0.52); p-value for interaction by gender ¼ 0.096]. All
results, including stratiﬁed by gender, were similar for the outcome of
incident WKROA.
Conclusions:We found no signiﬁcant protective effect of statin use on the
risk of incident knee ROA at 30 months, and can exclude a greater than 20%
reduction in the odds of TFROA with 95% conﬁdence. Because this is an
observational study, residual confounding by indication may in part
explain these results.306
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Purpose: Medial opening wedge high tibial osteotomy (HTO) aims to
improve pain and function by correcting varus alignment and lessening
aberrant loads on the medial compartment of the tibiofemoral joint.
Because varus gonarthrosis often affects both knees, staged bilateral HTO
may be an appropriate treatment approach for such patients. However, we
are unaware of any previous studies evaluating outcomes after these
staged procedures. Objectives of the present study were: 1) To evaluate
changes in radiographic alignment, dynamic knee joint loading, patient-
reported and performance-based outcomes after staged bilateral medial
opening wedge HTO, and 2) To compare outcomes in patients having the
second surgery staged either within or beyond 12 months of the ﬁrst
surgery.
Methods: Using a prospective case series design (level of evidence 4), 37
patients with bilateral varus alignment (-8.36  2.98) and medial
compartment osteoarthritis (OA) underwent staged bilateral medial
opening wedge HTO. Patients underwent full-limb standing ante-
roposterior radiographs to determine frontal plane alignment (mechanical
axis angle) and 3-dimensional gait analysis to estimate knee joint loadsMEN
Continuous use No use Continuous use
196 479 236
287 754 368
%) 37 (11.4%) 53 (6.6%) 23(5.9%)
1.57 (1.02-2.40) 0.04 ref 1.57(1.02-2.40) 0.04
1.37 (0.88-2.15) 0.16 0.84 (0.51-1.41) 0.52
